WANYI SCIENCE(688600)

Search documents
皖仪科技:独立董事关于第五届董事会第十一次会议相关事项的独立意见
2023-11-15 10:34
安徽皖仪科技股份有限公司独立董事 关于第五届董事会第十一次会议相关事项的独立意见 根据中国证券监督管理委员会《上市公司独立董事管理办法》《上海证券交 易所科创板股票上市规则》(以下简称"《上市规则》")《上海证券交易所科创板 上市公司自律监管指引第 1 号——规范运作》《公司章程》和《公司独立董事工 作制度》等有关规定,作为安徽皖仪科技股份有限公司(以下简称"公司"、"本 公司")的独立董事,本着真实、忠诚及勤勉的工作态度,基于独立、认真、谨 慎的立场,现就公司于 2023 年 11 月 15 日召开的第五届董事会第十一次会议相 关事项发表独立意见如下: 关于以集中竞价交易方式回购公司股份方案的独立意见 1.本次回购股份方案符合《中华人民共和国公司法》《中华人民共和国证券 法》《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号— —回购股份》《上市规则》等法律法规及规范性文件和《公司章程》的相关规定, 董事会会议表决程序符合相关法律、法规和《公司章程》的相关规定。 (本页无正文,为《安徽皖仪科技股份有限公司独立董事关于第五届董事会第十 一次会议相关事项的独立意见》之签字页) 独立董事签名: ...
皖仪科技(688600) - 2023 Q3 - 季度财报
2023-10-24 16:00
Financial Performance - The company's operating revenue for Q3 2023 was ¥194,654,432.01, representing a year-on-year increase of 12.30%[5] - The net profit attributable to shareholders decreased by 62.88% to ¥7,166,026.24 compared to the same period last year[5] - The basic earnings per share for Q3 2023 was ¥0.05, down 64.29% year-on-year[6] - Total operating revenue for the first three quarters of 2023 reached ¥505,074,695.64, an increase of 14.06% compared to ¥442,852,867.02 in the same period of 2022[20] - Net profit for the first three quarters of 2023 was ¥18,018,438.62, a decrease of 36.67% from ¥28,204,447.53 in the same period of 2022[21] - Basic and diluted earnings per share for the third quarter of 2023 were both ¥0.13, down from ¥0.19 in the same quarter of 2022[22] Research and Development - Research and development expenses totaled ¥43,518,538.71, accounting for 22.36% of operating revenue, an increase of 2.27 percentage points[6] - Research and development expenses for the first three quarters of 2023 totaled ¥117,926,276.95, an increase of 14.93% compared to ¥102,597,364.07 in the previous year[20] Assets and Liabilities - Total assets increased by 12.54% to ¥1,389,690,833.42 compared to the end of the previous year[6] - Total current assets as of September 30, 2023, amount to ¥1,114,397,365.89, an increase from ¥1,017,284,712.47 in the previous year[17] - Total liabilities as of September 30, 2023, are ¥509,511,836.58, compared to ¥349,448,754.42 in the previous year, indicating a significant increase[18] - The company’s total assets reached ¥1,389,690,833.42, up from ¥1,234,866,138.32 year-over-year[17] - The total equity attributable to shareholders decreased slightly by 0.59% to ¥880,178,996.84 compared to the end of the previous year[6] - The total equity attributable to shareholders is reported at ¥634,178,996.84 as of September 30, 2023[18] Cash Flow - The cash flow from operating activities for the year-to-date period was ¥76,147,809.38[6] - Cash flow from operating activities for the first three quarters of 2023 was ¥76,147,809.38, a significant improvement from a negative cash flow of ¥23,307,605.85 in the same period of 2022[22] - The net cash flow from investment activities was -$60,773,835.58, compared to -$38,817,968.47 in the previous year, indicating a decline in investment performance[23] - The net cash flow from financing activities was -$4,978,977.80, an improvement from -$23,360,904.17 in the same quarter last year, showing better cash management[23] - The company reported a net increase in cash and cash equivalents of $10,394,996.00, contrasting with a decrease of -$85,486,478.49 in the previous year[23] - Cash received from investment activities totaled $422,257,892.18, down from $634,475,497.83 year-over-year, highlighting a reduction in investment returns[23] Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,155[13] - The largest shareholder, Zang Mu, holds 38.82% of shares, totaling 52,096,834 shares[14] Other Income and Expenses - The company reported a decrease in government subsidies included in other income, which significantly impacted net profit[10] - Other income for the first three quarters of 2023 was ¥28,433,928.94, down 42.14% from ¥49,233,131.53 in the previous year[20] - The company reported an investment income of ¥6,176,128.51 for the first three quarters of 2023, a decrease from ¥7,968,576.96 in the same period of 2022[20]
皖仪科技:独立董事关于第五届董事会第十次会议相关事项的独立意见
2023-10-24 10:08
安徽皖仪科技股份有限公司独立董事 关于第五届董事会第十次会议相关事项的独立意见 根据中国证券监督管理委员会《关于上市公司建立独立董事制度的指导意 见》、《上海证券交易所科创板股票上市规则》(以下简称"《上市规则》")《上海 证券交易所科创板上市公司自律监管指引第 1 号——规范运作》、皖仪科技《公 司章程》和《独立董事工作制度》等有关规定,作为安徽皖仪科技股份有限公司 (以下简称"公司"、"本公司"或"皖仪科技")的独立董事,本着真实、忠诚 及勤勉的工作态度,基于独立、认真、谨慎的立场,现就公司第五届董事会第十 次会议相关事项发表独立意见如下: 关于公司使用闲置自有资金进行现金管理的独立意见 经对《关于使用闲置自有资金进行现金管理的议案》进行审查后,公司独立 董事认为,在不影响公司主营业务正常开展,保证运营资金需求和风险可控的前 提下,公司使用最高不超过 10,000 万元的闲置自有资金进行现金管理,有利于 提高公司闲置自有资金的使用效率和效果,进一步提高公司整体收益,符合全体 股东的利益。因此,独立董事一致同意公司使用闲置自有资金进行现金管理。 (以下无正文) (本页无正文,为《安徽皖仪科技股份有限公司独立 ...
皖仪科技:关于修订《公司章程》并办理工商变更登记的公告
2023-10-24 10:08
证券代码:688600 证券简称:皖仪科技 公告编号:2023-033 安徽皖仪科技股份有限公司 关于修订《公司章程》并办理工商变更登记的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 安徽皖仪科技股份有限公司(以下简称"公司"或"皖仪科技")于 2023 年 10 月 24 日召开了第五届董事会第十次会议,审议通过了《关于修订〈公司章 程〉并办理工商变更登记的议案》。现将有关情况公告如下: 一、公司注册资本变更情况 2023 年 4 月 25 日,公司召开的第五届董事会第七次会议通过了《关于作废 处理部分限制性股票的议案》和《关于公司 2021 年限制性股票激励计划首次授 予部分第二个归属期和预留授予部分第一个归属期符合归属条件的议案》,2023 年 5 月 26 日,公司 2021 年限制性股票激励计划首次授予部分第二个归属期和预 留授予部分第一个归属期的股份登记手续已完成,中国证券登记结算有限责任公 司上海分公司出具了《证券变更登记证明》。本次限制性股票归属完成后,公司 股本总数由 133,772,630 股增加至 ...
皖仪科技:第五届监事会第十次会议决议公告
2023-10-24 10:08
证券代码:688600 证券简称:皖仪科技 公告编号:2023-031 (一)审议通过《关于公司 2023 年第三季度报告的议案》 监事会认为:公司 2023 年第三季度报告的编制、内容和审议程序符合法律、 法规、中国证监会和上海证券交易所的各项规定和要求。公司 2023 年第三季度 报告公允地反映了公司 2023 年第三季度的财务状况和经营成果,全体监事保证 公司 2023 年第三季度报告的内容真实、准确、完整,不存在任何虚假记载、误 导性陈述或者重大遗漏。 具体内容详见公司同日在上海证券交易所网站(www.sse.com.cn)披露的《安 徽皖仪科技股份有限公司 2023 年第三季度报告》。 表决结果:同意 3 票,反对 0 票,弃权 0 票。 (二)审议通过《关于使用闲置自有资金进行现金管理的议案》 监事会认为:公司利用闲置自有资金进行现金管理,在授权额度内可以循环 使用,有利于提高公司闲置自有资金的使用效率,增加公司的收益,不存在损害 公司以及股东利益的情形,不影响公司的正常生产经营,符合相关法律法规的要 求。同意公司使用闲置自有资金进行现金管理。 安徽皖仪科技股份有限公司 第五届监事会第十次会议决议 ...
皖仪科技:公司章程(2023年10月)
2023-10-24 10:08
安徽皖仪科技股份有限公司 章 程 二〇二三年十月 目 录 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第四章 股东和股东大会 第一节 股东 第二节 股东大会的一般规定 第三节 股东大会的召集 第六节 股东大会的表决和决议 第五章 董事会 第一节 董事 第二节 董事会 第六章 总经理及其他高级管理人员 第四节 股东大会的提案与通知 第五节 股东大会的召开 第七章 监事会 第一节 监事 第二节 监事会 第八章 财务会计制度、利润分配和审计 1 第一章 总则 第二章 经营宗旨和经营范围 第三章 股份 2 第一节 财务会计制度 第二节 利润分配 第三节 内部审计 第四节 会计师事务所的聘任 第九章 通知与公告 第一节 通知 第二节 公告 第十章 合并、分立、增资、减资、解散和清算 第一节 合并、分立、增资和减资 第二节 解散和清算 第十一章 修改章程 第十二章 附则 第一章 总则 第一条 为规范安徽皖仪科技股份有限公司(以下简称"公司")的组织和行 为,保障公司、股东及债权人的合法权益,根据《中华人民共和国公司法》(以 下简称《公司法》)、《中华人民共和国证券法》(以下简称《证券法》)和其他有 关规定 ...
皖仪科技:关于使用闲置自有资金进行现金管理的公告
2023-10-24 10:08
证券代码:688600 证券简称:皖仪科技 公告编号:2023-032 安徽皖仪科技股份有限公司 关于使用闲置自有资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: (二)资金来源 本次公司进行现金管理的资金来源为公司暂时闲置自有资金,不影响公司正 常经营。 (三)额度及期限 使用最高不超过人民币 10,000 万元的暂时闲置自有资金进行现金管理,使 用期限不超过 12 个月,自董事会审议通过之日起 12 个月之内有效。在前述额度 及期限范围内,公司可以循环滚动使用。 (四)投资产品品种 ●安徽皖仪科技股份有限公司拟使用额度不超过人民币 10,000 万元(包含 本数)的闲置自有资金进行现金管理。 ●独立董事发表了同意的独立意见。 安徽皖仪科技股份有限公司(以下简称"公司"或"皖仪科技")于 2023 年 10 月 24 日召开第五届董事会第十次会议、第五届监事会第十次会议,审议通 过了《关于使用闲置自有资金进行现金管理的议案》,同意公司使用最高不超过 人民币 10,000 万元的暂时闲置自 ...
皖仪科技:国新证券股份有限公司关于安徽皖仪科技股份有限公司2023年半年度持续督导跟踪报告
2023-09-14 09:41
国新证券股份有限公司 关于安徽皖仪科技股份有限公司 2023 年半年度持续督导跟踪报告 国新证券股份有限公司(以下简称"保荐机构"或"国新证券")作为安徽 皖仪科技股份有限公司(以下简称"皖仪科技"或"公司")首次公开发行并在 科创板上市的持续督导保荐机构,根据《证券发行上市保荐业务管理办法》、《上 海证券交易所科创板股票上市规则》和《上海证券交易所上市公司自律监管指引 第 11 号——持续督导》等有关法律、法规和规范性文件的要求,出具 2023 年半 年度持续督导跟踪报告。 | 序号 | 工作内容 | 持续督导情况 | | --- | --- | --- | | | 建立健全并有效执行持续督导工作制度, | 保荐机构已建立健全并有效执行了持 | | 1 | 并针对具体的持续督导工作制定相应的工 | 续督导制度,并制定了相应的工作计 | | | 作计划。 | 划。 | | | 根据中国证监会相关规定,在持续督导工 作开始前,与上市公司签署持续督导协议, | 保荐机构已与皖仪科技签订相关协议, | | 2 | 明确双方在持续督导期间的权利义务,并 | 协议中明确了双方在持续督导期间的 | | | | 权利和义务 ...
皖仪科技:关于召开2023年半年度业绩说明会的公告
2023-09-14 09:31
证券代码:688600 证券简称:皖仪科技 公告编号:2023-030 会议召开时间:2023 年 9 月 22 日(星期五)上午 11:00-12:00 会议召开地点:上海证券交易所上证路演中心(网址: https://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 投资者可于 2023 年 9 月 15 日(星期五)至 9 月 21 日(星期四)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zqb@wayeal.com.cn 进行提问。公司将在说明会上对投资者普遍关注的 问题进行回答。 安徽皖仪科技股份有限公司 关于召开 2023 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 安徽皖仪科技股份有限公司(以下简称"公司")已于 2023 年 8 月 26 日发 布公司 2023 年半年度报告,为便于广大投资者更全面深入地了解公司 2022 年 半年度经营成果、财务状况,公司计划于 2023 年 9 月 22 日上午 ...
皖仪科技(688600) - 2023 Q2 - 季度财报
2023-08-25 16:00
Financial Performance - The company reported a total revenue of RMB 500 million for the first half of 2023, representing a year-on-year increase of 15%[13]. - The company has set a revenue guidance of RMB 1.2 billion for the full year 2023, reflecting an expected growth of 10% compared to 2022[13]. - The company's operating revenue for the first half of the year reached ¥310,420,263.63, representing a 15.17% increase compared to ¥269,523,288.39 in the same period last year[19]. - Net profit attributable to shareholders increased by 72.16% to ¥10,852,412.38 from ¥6,303,517.56 year-on-year[21]. - Basic and diluted earnings per share rose by 60.00% to ¥0.08 from ¥0.05 in the previous year[20]. - The company's total assets increased by 8.76% to ¥1,343,059,069.90 from ¥1,234,866,138.32 at the end of the previous year[19]. - The company's total revenue for the first half of 2023 was reported at 60,327.40 million RMB, with a net profit of 7,440.78 million RMB, representing a significant increase compared to the previous year[50]. - The company reported a total revenue of 1.5 billion CNY for the first half of 2023, representing a year-over-year increase of 15%[102]. - The gross margin for the first half of 2023 was reported at 40%, a slight improvement from 38% in the previous year[102]. User Growth and Market Expansion - User data indicates a growth in active users by 20%, reaching a total of 1 million active users by June 30, 2023[13]. - Market expansion efforts have led to a 30% increase in market share in the domestic market[13]. - The company is focusing on expanding its market presence in biochemical, food analysis, pharmaceutical research, and environmental analysis sectors[45]. - The company is investing $50 million in R&D for new technologies aimed at enhancing user experience[99]. - Market expansion plans include entering three new international markets by Q4 2023, targeting an additional 500,000 users[99]. Research and Development - The company is investing RMB 50 million in R&D for new technologies aimed at enhancing product efficiency and compliance with environmental standards[13]. - The company achieved a total R&D expenditure of ¥74,407,738.24, representing a 9.79% increase compared to ¥67,773,419.63 in the same period last year[42]. - Research and development expenses accounted for 23.97% of operating revenue, a decrease of 1.18 percentage points from the previous year[20]. - The R&D personnel count increased to 508, representing 39.91% of the total workforce, up from 33.51% in the previous year[54]. - The company has established a research and development model that prioritizes independent research while collaborating with research institutions[31]. Product Development and Innovation - New product launches in the environmental monitoring sector contributed to a 25% increase in sales volume during the reporting period[13]. - The company maintains a focus on developing leak detection instruments and online monitoring instruments, serving various industries including environmental protection and pharmaceuticals[26]. - The company has developed a complete product line including leak detection instruments, online monitoring instruments, and laboratory analysis instruments, ensuring a robust production and quality control system[58]. - The company has been recognized for its innovative products, including the CEMS1000 continuous emission monitoring system, which has been designated as a national key new product[55]. - The company aims to achieve industry-leading levels in various projects, with significant improvements in efficiency and sensitivity compared to traditional methods[45][46]. Strategic Acquisitions and Investments - The company has completed a strategic acquisition of a competitor, which is expected to enhance its product offerings and market presence[13]. - The company announced a strategic acquisition of a competitor for $200 million to enhance market share[99]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of 300 million CNY allocated for potential deals[102]. Financial Management and Risks - The management highlighted potential risks related to regulatory changes that could impact future operations[4]. - The company faces risks related to reliance on government subsidies, which have supported its R&D and operational performance; any reduction in such support could adversely affect future earnings[65]. - The company is exposed to competition from both domestic and international brands, necessitating ongoing innovation and market adaptation to maintain its competitive edge[66]. - The company has identified risks associated with talent acquisition and retention, which are critical for sustaining its core technological capabilities amid expanding operations[67]. Environmental Commitment - The company is committed to developing environmentally friendly technologies, significantly reducing solvent consumption in its processes[45]. - The company has established an environmental protection mechanism and invested 200,000 RMB in environmental protection during the reporting period[91]. - The company does not belong to high-pollution industries and has implemented measures to manage waste, including wastewater, waste gas, and solid waste[92][93]. Shareholder and Governance Matters - The board of directors confirmed that the financial report is accurate and complete, with no significant omissions[5]. - The company has a policy that limits the annual transfer of pre-IPO shares to 25% of the total shares held, with a minimum selling price equal to the IPO price[97]. - The company has committed to not transferring or entrusting the management of its pre-IPO shares for 36 months from the date of listing[96]. - The company will ensure that the public offering of shares does not involve any fraudulent issuance[104]. Operational Efficiency - The company aims to reduce operational costs by 5% through efficiency improvements in the supply chain[99]. - The company is enhancing its internal management capabilities through digital upgrades, including ERP and financial systems, to improve operational efficiency[62]. - The company’s sales expenses decreased by 3.24%, attributed to improved management of sales costs during the reporting period[70].